NEW YORK Michael Pearson, the former chief executive officer of Valeant Pharmaceuticals International (VRX.TO), has signed a consulting agreement with the drugmaker that will run through 2017 and pay him hundreds of thousands of dollars, according to the separation agreement filed with regulators.
Pearson, who left Valeant on May 2 after a year in which it had drawn scrutiny for its sharp drug price increases, financial relationship with a specialty pharmacy and accounting practices, can earn $83,333 a month this year as a consultant.
00:12 Trump’s America will be on vivid display at annual conservative gathering15
18:32 Magic Johnson takes over the Lakers, ousts Mitch Kupchak and Jim Buss in stunning front-office shakeup12
04:03 Uber CEO calls for 'urgent investigation' into former engineer's sexual harassment claims23
23:08 Former Uber engineer details sexism nightmare, CEO orders investigation24